Jane Street’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $18.3M | Buy |
4,393,853
+219,967
| +5% | +$836K | ﹤0.01% | 2232 |
|
|
2026
Q1 | $14.7M | Buy |
4,173,886
+590,076
| +16% | +$1.89M | ﹤0.01% | 2089 |
|
|
2025
Q4 | $9.78M | Buy |
3,583,810
+2,170,148
| +154% | +$5.02M | ﹤0.01% | 2346 |
|
|
2025
Q3 | $3.07M | Sell |
1,413,662
-593,909
| -30% | -$1.4M | ﹤0.01% | 4178 |
|
|
2025
Q2 | $3.45M | Buy |
2,007,571
+1,886,481
| +1,558% | +$4.69M | ﹤0.01% | 3545 |
|
|
2025
Q1 | $403K | Sell |
121,090
-174,138
| -59% | -$898K | ﹤0.01% | 7260 |
|
|
2024
Q4 | $2.18M | Buy |
295,228
+178,258
| +152% | +$1.65M | ﹤0.01% | 3948 |
|
|
2024
Q3 | $1.1M | Sell |
116,970
-913,342
| -89% | -$8.65M | ﹤0.01% | 5692 |
|
|
2024
Q2 | $8.26M | Buy |
1,030,312
+9,245
| +0.9% | +$99.1K | ﹤0.01% | 2255 |
|
|
2024
Q1 | $15.1M | Buy |
1,021,067
+498,506
| +95% | +$5.8M | ﹤0.01% | 1426 |
|
|
2023
Q4 | $4.25M | Sell |
522,561
-27,354
| -5% | -$143K | ﹤0.01% | 3086 |
|
|
2023
Q3 | $2.5M | Buy |
549,915
+147,598
| +37% | +$964K | ﹤0.01% | 3674 |
|
|
2023
Q2 | $2.83M | Buy |
402,317
+336,633
| +513% | +$2.41M | ﹤0.01% | 3601 |
|
|
2023
Q1 | $401K | Sell |
65,684
-36,235
| -36% | -$250K | ﹤0.01% | 6709 |
|
|
2022
Q4 | $651K | Buy |
101,919
+41,101
| +68% | +$321K | ﹤0.01% | 5692 |
|
|
2022
Q3 | $583K | Sell |
60,818
-69,299
| -53% | -$799K | ﹤0.01% | 6403 |
|
|
2022
Q2 | $1.44M | Sell |
130,117
-181,203
| -58% | -$2.37M | ﹤0.01% | 4794 |
|
|
2022
Q1 | $5.18M | Buy |
311,320
+141,703
| +84% | +$2.19M | ﹤0.01% | 2975 |
|
|
2021
Q4 | $3.24M | Buy |
169,617
+57,383
| +51% | +$1.26M | ﹤0.01% | 3563 |
|
|
2021
Q3 | $2.77M | Sell |
112,234
-19,762
| -15% | -$466K | ﹤0.01% | 3821 |
|
|
2021
Q2 | $3.43M | Buy |
131,996
+48,609
| +58% | +$1.26M | ﹤0.01% | 3328 |
|
|
2021
Q1 | $2.64M | Sell |
83,387
-19,750
| -19% | -$819K | ﹤0.01% | 3501 |
|
|
2020
Q4 | $4.79M | Sell |
103,137
-70,371
| -41% | -$2.79M | ﹤0.01% | 2183 |
|
|
2020
Q3 | $5.71M | Sell |
173,508
-216,990
| -56% | -$6.65M | ﹤0.01% | 1717 |
|
|
2020
Q2 | $10.7M | Buy |
390,498
+327,885
| +524% | +$10.8M | 0.01% | 1136 |
|
|
2020
Q1 | $1.87M | Buy |
62,613
+33,358
| +114% | +$884K | ﹤0.01% | 2083 |
|
|
2019
Q4 | $810K | Sell |
29,255
-3,727
| -11% | -$84.8K | ﹤0.01% | 3060 |
|
|
2019
Q3 | $600K | Sell |
32,982
-9,742
| -23% | -$215K | ﹤0.01% | 3314 |
|
|
2019
Q2 | $1.05M | Buy |
+42,724
| New | +$644K | ﹤0.01% | 2635 |
|
|
2017
Q4 | – | Sell |
-21,204
| Closed | -$164K | – | 4866 |
|
|
2017
Q3 | $164K | Buy |
+21,204
| New | +$134K | ﹤0.01% | 4179 |
|
Other funds holding IOVA
MFM
PAI
Jane Street's IOVA Position: Q2 2026 in Review
Jane Street increased its Iovance Biotherapeutics (IOVA) stake by 5.3% in Q2 2026, buying an estimated $836K and bringing the position to 4,393,853 shares worth $18.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2232.
Jane Street first reported a position in IOVA in Q3 2017 and has held it in 30 quarters since. 292 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.
- Jane Street held 4,393,853 shares of Iovance Biotherapeutics worth $18.3M as of Q2 2026.
- Jane Street bought 219,967 Iovance Biotherapeutics shares in Q2 2026, an estimated $836K.
- Iovance Biotherapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #2232 holding.
- Jane Street first reported a position in Iovance Biotherapeutics in Q3 2017 and has held it in 30 quarters since.
- 292 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.